Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)

About the company

Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

9

$NoneM

Total Revenue

9

Employees

$33.21M

Market Capitalization

-1.92

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 391056.16 82729.00 6.28 22.79 20.75
Pfizer Inc. PFE 198619.60 50660.00 3.01 12.57 31.17
Merck & Co., Inc. MRK 198480.10 48081.00 7.45 19.58 21.10
Eli Lilly & Co. LLY 148789.44 23087.00 50.49 26.23 23.97
AbbVie, Inc. ABBV 145224.24 34057.00 -23.24 17.32 24.65
Bristol Myers Squibb Co. BMY 107221.81 31006.00 2.60 91.16 3.08
Repligen Corp. RGEN 6248.01 286.00 5.99 272.24 8.11
Reata Pharmaceuticals, Inc. RETA 4786.40 20.00 22.67 -15.39 -150.30
Nektar Therapeutics NKTR 4111.36 137.00 3.21 -8.95 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3862.82 1.00 35.71 -5.91 None
Allakos, Inc. ALLK 3177.20 None 6.90 -33.97 None
OPKO Health, Inc. OPK 2356.83 891.00 1.68 -8.06 -32.92
Karuna Therapeutics, Inc. KRTX 2343.38 None 6.12 -57.78 None
ADC Therapeutics SA ADCT 2338.74 2.00 27.59 -20.05 None
Turning Point Therapeutics, Inc. TPTX 2157.84 None 6.49 -18.05 None
Apellis Pharmaceuticals, Inc. APLS 2141.70 None 9.46 -5.13 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
IGM Biosciences, Inc. IGMS 2038.87 None 8.98 -37.58 None
Principia Biopharma, Inc. PRNB 1752.24 30.00 6.24 -24.93 -242.01
Springworks Therapeutics, Inc. SWTX 1554.02 None 5.05 -24.92 None
Y-mAbs Therapeutics, Inc. YMAB 1436.71 None 8.80 -15.59 None
Zymeworks, Inc. ZYME 1393.98 26.00 2.89 -8.22 -629.37
Tricida, Inc. TCDA 1263.22 None 6.49 -5.98 None
Akcea Therapeutics, Inc. AKCA 1232.87 341.00 2.53 -43.83 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1169.85 None 6.06 -9.67 None
Akero Therapeutics, Inc. AKRO 1092.43 None 9.12 -21.53 None
Odonate Therapeutics, Inc. ODT 1084.89 None 8.89 -9.64 None
Phibro Animal Health Corp. PAHC 1039.35 818.00 5.25 28.17 4.49
Arcutis Biotherapeutics, Inc. ARQT 1020.09 None 4.35 -16.31 None
Athenex, Inc. ATNX 971.88 123.00 5.96 -9.03 -87.86
Constellation Pharmaceuticals, Inc. CNST 906.88 None 4.27 -9.77 None
Gossamer Bio, Inc. GOSS 774.70 None 3.14 -3.90 None
G1 Therapeutics, Inc. GTHX 763.80 1.00 3.31 -5.83 None
Phathom Pharmaceuticals, Inc. PHAT 735.75 None 4.08 -2.70 None
Quanterix Corp. QTRX 726.84 60.00 6.41 -16.62 -71.52
Oric Pharmaceuticals, Inc. ORIC 680.40 None -7.39 -22.50 None
Amneal Pharmaceuticals, Inc. AMRX 672.67 1679.00 4.63 -3.09 -11.85
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 655.98 19.00 60.80 -23.58 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Krystal Biotech, Inc. KRYS 641.92 None 3.74 -30.95 None
Applied Therapeutics, Inc. APLT 617.54 14.00 3.99 -12.53 -19.41
Keros Therapeutics, Inc. KROS 596.88 8.00 -26.96 -28.10 -285.35
Aprea Therapeutics, Inc. APRE 569.31 None 5.04 -16.84 None
Oyster Point Pharma, Inc. OYST 513.24 None 5.16 -8.92 None
Mirum Pharmaceuticals, Inc. MIRM 465.50 None 3.03 -6.87 None
SIGA Technologies, Inc. SIGA 460.84 19.00 5.16 -23.42 -94.00
89bio, Inc. ETNB 444.50 None 5.48 -6.89 None
Biospecifics Technologies Corp. BSTC 441.21 40.00 3.58 18.87 61.80
Fulcrum Therapeutics, Inc. FULC 423.89 1.00 7.14 -6.14 None
Satsuma Pharmaceuticals, Inc. STSA 417.01 None 4.10 -11.46 None
Osmotica Pharmaceuticals Plc OSMT 416.88 232.00 3.16 -1.52 -115.44
DURECT Corp. DRRX 390.60 28.00 30.00 -16.15 -82.94
Imara, Inc. IMRA 375.70 None 3.63 -10.68 None
TCR2 Therapeutics, Inc. TCRR 368.88 None 2.52 -36.60 None
Kala Pharmaceuticals, Inc. KALA 365.76 6.00 4.00 -3.98 None
Relmada Therapeutics, Inc. RLMD 363.42 0.00 5.42 -30.36 -877.66
Ocular Therapeutix, Inc. OCUL 353.04 6.00 -43.26 -3.85 None
Crinetics Pharmaceuticals, Inc. CRNX 350.16 1.00 4.42 -6.00 -447.78
Ovid Therapeutics, Inc. OVID 315.00 None 7.45 -4.83 None
IDEAYA Biosciences, Inc. IDYA 283.40 None 4.31 -6.50 None
Aeglea Biotherapeutics, Inc. AGLE 276.54 4.00 8.73 -3.45 -523.27
Urovant Sciences Ltd. UROV 276.00 None -4.89 -1.91 None
HOOKIPA Pharma, Inc. HOOK 250.12 13.00 2.26 -5.53 -333.02
AMAG Pharmaceuticals, Inc. AMAG 246.16 321.00 0.94 -0.66 -115.05
Spero Therapeutics, Inc. SPRO 242.63 12.00 3.19 -2.98 -656.72
Verrica Pharmaceuticals, Inc. VRCA 220.00 None 4.02 -7.21 None
Lannett Co., Inc. LCI 218.12 542.00 0.75 -7.17 -5.77
Sutro Biopharma, Inc. STRO 207.46 41.00 3.94 -3.40 -148.06
KalVista Pharmaceuticals, Inc. KALV 207.00 13.00 2.45 -7.01 -229.44
Veru, Inc. VERU 189.15 39.00 6.47 -19.40 -25.53
Kaleido Biosciences, Inc. KLDO 184.50 None 6.54 -2.52 None
Galera Therapeutics, Inc. GRTX 183.75 None 3.43 -2.79 None
LogicBio Therapeutics, Inc. LOGC 171.35 1.00 5.17 -4.03 None
Protara Therapeutics, Inc. TARA 153.54 None 2.31 -9.96 None
Liquidia Technologies, Inc. LQDA 152.57 8.00 11.96 -3.10 -602.17
Avenue Therapeutics, Inc. ATXI 149.92 532.00 27.56 -10.30 26.69
Gritstone Oncology, Inc. GRTS 144.72 4.00 1.30 -1.39 None
scPharmaceuticals, Inc. SCPH 139.08 119.00 3.55 -4.44 -27.05
Lyra Therapeutics, Inc. LYRA 138.12 1.00 -1.17 -8.28 -491.16
PhaseBio Pharmaceuticals, Inc. PHAS 137.17 2.00 2.54 -2.87 None
Tyme Technologies, Inc. TYME 136.85 None 7.93 -6.26 None
Evelo Biosciences, Inc. EVLO 132.80 None 4.88 -1.51 None
Ayala Pharmaceuticals, Inc. AYLA 132.48 3.00 -3.12 -6.42 -679.19
Harrow Health, Inc. HROW 127.66 51.00 8.18 -5.17 -47.54
TFF Pharmaceuticals, Inc. TFFP 127.11 None 4.92 -3.28 None
Cyclerion Therapeutics, Inc. CYCN 125.28 6.00 1.58 -1.21 None
Mustang Bio, Inc. MBIO 120.40 None 2.81 -2.45 None
Corvus Pharmaceuticals, Inc. CRVS 118.90 None 1.91 -2.52 None
Immunic, Inc. IMUX 118.50 None 3.49 -53.86 None
Aquestive Therapeutics, Inc. AQST 117.88 49.00 -6.79 -1.68 -139.64
NeuBase Therapeutics, Inc. NBSE 110.08 None 46.25 -2.46 None
Evolus, Inc. EOLS 91.80 45.00 1.65 -0.91 -217.51
Eton Pharmaceuticals, Inc. ETON 89.28 1.00 9.73 -4.47 None
Trevi Therapeutics, Inc. TRVI 88.56 None 1.88 -3.02 None
Milestone Pharmaceuticals, Inc. MIST 88.00 None 0.87 -1.41 None
EyePoint Pharmaceuticals, Inc. EYPT 77.97 26.00 5.50 -1.59 -196.30
Xeris Pharmaceuticals, Inc. XERS 76.72 4.00 3.81 -0.59 None
Clearside Biomedical, Inc. CLSD 71.34 6.00 9.16 -4.05 -293.61
Aridis Pharmaceuticals, Inc. ARDS 67.05 1.00 -27.59 -2.29 -851.00
Navidea Biopharmaceuticals, Inc. NAVB 64.77 1.00 -47.62 -5.86 -65.13
Checkpoint Therapeutics, Inc. CKPT 64.60 2.00 5.57 -2.78 -949.53
Baudax Bio, Inc. BXRX 63.54 None -1.73 -0.91 None
BiomX, Inc. PHGE 60.50 None 1.59 -1.41 None
Assertio Therapeutics, Inc. ASRT 58.64 192.00 1.02 -0.36 -83.99
Genprex, Inc. GNPX 55.10 None 4.68 -4.03 None
Aerpio Pharmaceuticals, Inc. ARPO 49.20 20.00 1.48 -2.61 -51.58
Menlo Therapeutics, Inc. MNLO 46.98 2.00 3.95 -0.50 -483.51
Eyenovia, Inc. EYEN 42.56 None 4.29 -2.08 None
Annovis Bio, Inc. ANVS 42.28 None 3.87 -33.56 None
Edesa Biotech, Inc. EDSA 41.85 0.00 5.96 -0.44 -395.23
Moleculin Biotech, Inc. MBRX 36.85 None 3.20 -4.00 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Adamis Pharmaceuticals Corp. ADMP 35.44 22.00 1.36 -1.20 -140.33
AgeX Therapeutics, Inc. AGE 34.83 2.00 -45.84 -2.86 -658.11
Mannatech, Inc. MTEX 34.80 156.00 1.47 7.84 3.45
Citius Pharmaceuticals, Inc. CTXR 33.21 None 2.46 -1.92 None
Acer Therapeutics, Inc. ACER 33.00 3.00 2.41 -1.26 -274.69
Allena Pharmaceuticals, Inc. ALNA 31.28 None 4.12 -0.72 None
Oncternal Therapeutics, Inc. ONCT 31.07 3.00 3.98 -1.23 -225.89
CNS Pharmaceuticals, Inc. CNSP 27.04 None 4.69 -4.97 None
Hoth Therapeutics, Inc. HOTH 25.10 None 6.97 -2.79 None
Aileron Therapeutics, Inc. ALRN 24.60 None 3.51 -0.92 None
Millendo Therapeutics, Inc. MLND 24.15 0.00 0.57 -0.52 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Spring Bank Pharmaceuticals, Inc. SBPH 22.40 0.00 0.85 -0.86 None
ProPhase Labs, Inc. PRPH 19.08 9.00 1.73 -6.36 -31.15
Daré Bioscience, Inc. DARE 18.91 1.00 8.29 -1.13 None
Adial Pharmaceuticals, Inc. ADIL 14.80 None 3.61 -1.95 None
Novan, Inc. NOVN 14.48 5.00 -3.33 -0.46 -602.34
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
PDS Biotechnology Corp. PDSB 13.09 None 1.45 -0.51 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.52 None 0.64 -0.36 None
Brickell Biotech, Inc. BBI 4.50 5.00 1.48 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical Officer (CMO) and Executive Vice President

28m ago, source: Business Insider

PRNewswire/ -- Citius Pharmaceuticals, Inc. ('Citius' or the 'Company') (Nasdaq: CTXR), a specialty pharmaceutical ...

Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

1d ago, source: PR Newswire

CRANFORD, N.J., July 13, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical ...

CTXR Citius Pharmaceuticals, Inc. Common Stock

12d ago, source: Nasdaq

Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.

Citius Pharmaceuticals Inc.

12d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides

13d ago, source: Stockhouse

CRANFORD, N.J., June 29, 2020 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing ...

Citius Pharmaceuticals to Deliver Virtual Presentation at the Life Sciences Investor Forum

21d ago, source: YAHOO!

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that ...

BRIEF-Citius Receives FDA Response On Pre-IND Application For Acute Respiratory Distress Syndrome Treatment In Patients With Covid-19

17d ago, source: Reuters

CITIUS RECEIVES FDA RESPONSE ON PRE-INVESTIGATIONAL NEW DRUG (PIND) APPLICATION FOR ITS INDUCED MESENCHYMAL STEM CELLS (IMSCS) TO TREAT ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN PATIENTS WITH ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.